APT Medical Inc (688617) — Capital Reinvestment Ratio
Latest as of December 2025:
0.18x
APT Medical Inc (688617) has a Capital Reinvestment Ratio of 0.18x as of December 2025, meaning it reinvests 0% of its operating cash flow (CN¥294.68 Million) in capital expenditures (CN¥52.10 Million). See 688617 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.18x
Capex / Operating Cash Flow
Operating Cash Flow
CN¥294.68 Million
CNY
Capital Expenditures
CN¥52.10 Million
CNY
Data as of
Dec 2025
Most recent filing
APT Medical Inc Capital Reinvestment Ratio (2017–2025)
This chart tracks APT Medical Inc's Capital Reinvestment Ratio across 9 annual periods.
Annual Capital Reinvestment Ratio for APT Medical Inc (2017–2025)
Year-by-year Capital Reinvestment Ratio for APT Medical Inc from 2017 to 2025. For live market cap and broader valuation context, see 688617 company net worth.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.29x | CN¥975.30 Million | CN¥285.59 Million | ▼ -66.5% |
| 2024 | 0.87x | CN¥743.39 Million | CN¥650.24 Million | ▲ +198.3% |
| 2023 | 0.29x | CN¥689.06 Million | CN¥202.03 Million | ▼ -24.8% |
| 2022 | 0.39x | CN¥367.46 Million | CN¥143.21 Million | ▼ -57.8% |
| 2021 | 0.92x | CN¥181.39 Million | CN¥167.38 Million | ▲ +209.5% |
| 2020 | 0.30x | CN¥148.24 Million | CN¥44.20 Million | ▼ -75.8% |
| 2019 | 1.23x | CN¥54.90 Million | CN¥67.56 Million | ▼ -28.8% |
| 2018 | 1.73x | CN¥18.63 Million | CN¥32.20 Million | ▼ -11.7% |
| 2017 | 1.96x | CN¥12.91 Million | CN¥25.26 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow